Chemico-Biological Interactions 186 (2010) 16–23
Contents lists available at ScienceDirect
Chemico-Biological Interactions
journal homepage: www.elsevier.com/locate/chembioint
Anti-amyloidogenic effect of AA3E2 attenuates -amyloid induced toxicity in
SK-N-MC cells
Hamed Shaykhalishahi
a
, Mohammad Taghizadeh
a
, Razieh Yazdanparast
a,∗
, Young-Tae Chang
b
a
Institute of Biochemistry and Biophysics, P. O. Box 13145-1384, University of Tehran, Enghelab Ave, Tehran, Iran
b
Department of Chemistry, NUS MedChem Program of Life Sciences Institute, National University of Singapore, Singapore 117543, Singapore
article info
Article history:
Received 17 January 2010
Received in revised form 14 March 2010
Accepted 23 March 2010
Available online 30 March 2010
Keywords:
AA3E2
Anti-amyloidogenic
A1–42 fibril
Alzheimer’s disease
Docking
abstract
-Amyloid peptide (A) is believed to play a recognized role in pathogenesis of Alzheimer’s disease (AD).
Self-association of A peptide into amyloid fibrils causes neurotoxicity. Compounds capable of interfering
with A–A interaction through binding to nucleation sites can inhibit A amyloidogenesis and A-
induced cytotoxicity. AA3E2 is a triazine-derivative whose anti-amyloidogenic ability has previously
been established. In the present study, we evaluated the protective effect of AA3E3 against A
1–42
-induced
toxicity in SK-N-MC cell line. The cell exposure to the co-incubated A
1–42
with AA3E2 decreased the cell
viability loss dose-dependently, compared to cells exposed to A
1–42
fibrils.
Co-incubation with AA3E2 also attenuated the ROS production, activation of caspase-3 and the extent
of apoptotic cell death induced by A
1–42
fibril. Moreover, the 3D structure of the molecular associates
between A
1–42
and AA3E2 were theoretically determined by docking studies. Our docking data indi-
cated that AA3E2 inhibits the formation of A fibril likely via binding to the nucleation site within the
hydrophobic region of A (KLVFF). These observations provide the background for future design of more
elegant -breaking agents for dissolution of A fibrillar aggregates.
© 2010 Elsevier Ireland Ltd. All rights reserved.
1. Introduction
Alzheimer’s disease (AD) is the most common cause of demen-
tia and the fifth leading cause of death among Americans aging 65
and more with an afflicting rate of 70 s [1]. In the absence of effec-
tive therapeutic approaches, more than 25 million people would
be expected to be affected by AD in the near future [2]. One of the
histological hallmarks of AD is the presence of brain senile plaques.
The major constituent of these fibrillar plaques is a self-aggregating
peptide named -amyloid peptide (A) [3]. The A is generated by
the successive action of two proteases, - and -secretases, on the
amyloid precursor protein (APP) [4]. The most abundant variants of
A found in AD, are A
1–40
and A
1–42
containing 40 and 42 amino
acids, respectively. A
1–42
is the dominant form in senile plaques
and forms amyloid fibrils more rapidly than A
1–40
[5]. According
to amyloid cascade hypothesis, the fibrillar A aggregates induce
a cascade of events that lead to neuronal cell death [6]. The A
peptide is rich in hydrophobic regions of -sheet structures which
forms strong A–A intermolecular -sheet interactions, leading
to fibril formation [7]. Regarding this fact, it would be logical to
design therapeutic approach to disrupt the A–A interactions as
∗
Corresponding author. Tel.: +98 21 66956976; fax: +98 21 66404680.
E-mail address: yazdan@ibb.ut.ac.ir (R. Yazdanparast).
a means of attenuating the cytotoxicity of A aggregates [8–12].
In recent years, numerous approaches have been developed for
efficient high-throughput screening of fibril inhibitors and beta-
sheet breaker compounds [13,14]. AA3E2 is a triazine-derivative
(Scheme 1A) whose beta-sheet breaking activity has been demon-
strated by Kim et al. [13]. In addition, we have recently reported on
the protective effect of AA3E2 against A fibril in SK-N-MC cell line
through its anti-oxidant capacity [15], likely via its inhibitory effect
against hydrogen peroxide cytotoxicity [16]. In this investigation,
we were interested to further re-evaluate the molecular interac-
tion of AA3E2 structure with the molecular region of the target
using docking approaches. Our results clearly indicated that AA3E2
interacts with a hydrophobic region of the target A molecule hav-
ing the following sequence, KLVFF, and this interaction might be
the cause of lower cytotoxicity of the A aggregates.
2. Materials and methods
2.1. Materials
The cell culture medium (RPMI 1640) and penicillin–
streptomycin were purchased from Gibco BRL (Life technol-
ogy, Paisley, Scotland). Fetal bovine serum (FBS) was obtained
from Jahad Daneshgahi (Tehran, Iran). The culture plates were
obtained from Nunc (Denmark). Ethidium bromide (EtBr) and
0009-2797/$ – see front matter © 2010 Elsevier Ireland Ltd. All rights reserved.
doi:10.1016/j.cbi.2010.03.042